论文部分内容阅读
一、理论设想1.理论:近年来,由于免疫学的飞跃发展,对于细胞免疫的研究中,发现免疫淋巴细胞的可透析提取物,能将皮肤试验的反应性阳性的供体转移给阴性的受体。1954年Lawrence 氏首先提出,1955年他又命名这种提取物称为转移因子(TF)。通过一系列的实验室研究,一直到1975年 Alan 等氏才将 TF 用于治疗细胞免疫缺陷病 Wiskott-Aldrich(W—A)综合病征。于是 TF 在皮肤科等临床上,获得治疗与预防的研究。2.性质:TF 可从外周血液中的活的白细胞,经过脱氧核糖核酸酶处理及冷融方面
First, the theory envisaged 1. Theory: In recent years, due to the rapid development of immunology, for the study of cellular immunity, found that immune lymphocyte dialysis extract, skin test can be positive reactive donor transferred to negative Receptor. In 1954 Lawrence first proposed that in 1955 he also named the extract called transfer factor (TF). Through a series of laboratory studies, TF was used by Alan et al. In 1975 to treat Wiskott-Aldrich syndrome (W-A) syndrome. So TF in dermatology and other clinical, access to treatment and prevention research. 2. Properties: TF can be from the peripheral blood of living white blood cells, after DNA enzyme treatment and cold-melting aspects